InnoCare Pharma Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 738.54 million compared to CNY 625.4 million a year ago. Net loss was CNY 631.26 million compared to CNY 886.59 million a year ago.

Basic loss per share from continuing operations was CNY 0.37 compared to CNY 0.6 a year ago.